PL2114993T3 - Szczepionka - Google Patents

Szczepionka

Info

Publication number: PL2114993T3
Authority: PL; Poland
Prior art keywords: vaccine
Prior art date: 2007-01-15

Application number

PL08701434T

Other languages

English (en)

Inventor

Normand Blais

Denis Martin

Remi M Palmantier

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-15

Filing date

2008-01-11

Publication date

2013-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39300029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2114993(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-01-15 Priority claimed from GB0700760A external-priority patent/GB0700760D0/en

2007-01-23 Priority claimed from GB0701262A external-priority patent/GB0701262D0/en

2008-01-11 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2013-01-31 Publication of PL2114993T3 publication Critical patent/PL2114993T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001189—PRAME
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Microbiology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL08701434T 2007-01-15 2008-01-11 Szczepionka PL2114993T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0700760A GB0700760D0 (en)	2007-01-15	2007-01-15	Vaccine
GB0701262A GB0701262D0 (en)	2007-01-23	2007-01-23	Vaccine
PCT/EP2008/050290 WO2008087102A1 (en)	2007-01-15	2008-01-11	Vaccine
EP08701434A EP2114993B1 (en)	2007-01-15	2008-01-11	Vaccine

Publications (1)

Publication Number	Publication Date
PL2114993T3 true PL2114993T3 (pl)	2013-01-31

Family

ID=39300029

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08701434T PL2114993T3 (pl)	2007-01-15	2008-01-11	Szczepionka

Country Status (31)

Country	Link
US (1)	US20080187535A1 (pl)
EP (1)	EP2114993B1 (pl)
JP (1)	JP5391080B2 (pl)
KR (1)	KR20090101313A (pl)
CN (1)	CN101668770B (pl)
AR (1)	AR064862A1 (pl)
AU (1)	AU2008207025B2 (pl)
BR (1)	BRPI0806463A2 (pl)
CA (1)	CA2674552A1 (pl)
CL (1)	CL2008000104A1 (pl)
CO (1)	CO6210757A2 (pl)
CR (1)	CR10971A (pl)
CY (1)	CY1113760T1 (pl)
DK (1)	DK2114993T3 (pl)
DO (1)	DOP2009000167A (pl)
EA (1)	EA016326B1 (pl)
ES (1)	ES2393812T3 (pl)
HR (1)	HRP20120828T1 (pl)
IL (1)	IL199663A0 (pl)
JO (1)	JO2840B1 (pl)
MA (1)	MA31093B1 (pl)
MX (1)	MX2009007571A (pl)
MY (1)	MY153679A (pl)
NZ (1)	NZ578285A (pl)
PE (2)	PE20130324A1 (pl)
PL (1)	PL2114993T3 (pl)
PT (1)	PT2114993E (pl)
SI (1)	SI2114993T1 (pl)
TW (1)	TWI434697B (pl)
WO (1)	WO2008087102A1 (pl)
ZA (1)	ZA200904923B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2118128T1 (sl) *	2007-01-15	2013-02-28	Glaxosmithkline Biologicals S.A.	Fuzijski proteini, ki obsegajo tumorska zavrnitvena antigena NY-ESO-1 in LAGE-1
MX2011009597A (es)	2009-03-17	2012-05-29	Glaxosmithkline Biolog Sa	Deteccion mejorada de la expresion del gen.
WO2010141953A2 (en) *	2009-06-05	2010-12-09	The Ohio State University Research Foundation	Biomaterials, compositions, and methods
GB0910046D0 (en)	2009-06-10	2009-07-22	Glaxosmithkline Biolog Sa	Novel compositions
GB201008682D0 (en) *	2010-05-25	2010-07-07	Vib Vzw	Epitope tag for affinity based applications
GB201101331D0 (en) *	2011-01-26	2011-03-09	Glaxosmithkline Biolog Sa	Compositions and uses
AU2012288926A1 (en)	2011-07-22	2014-01-16	Glaxosmithkline Biologicals S.A.	PRAME purification
GB201114919D0 (en) *	2011-08-30	2011-10-12	Glaxosmithkline Biolog Sa	Method
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
RU2590701C2 (ru) *	2013-04-29	2016-07-10	Общество с ограниченной ответственностью "ГеноТехнология"	Антигенная композиция и ее терапевтическое применение для профилактики и лечения онкологических заболеваний, рекомбинантная плазмидная днк, обеспечивающая синтез гибридного белка, а также способ получения белка
WO2015050158A1 (ja)	2013-10-01	2015-04-09	国立大学法人三重大学	抗原提示を促進するエピトープ間配列を含むｔ細胞誘導ワクチン
CN105254767A (zh) *	2015-11-17	2016-01-20	重庆科润生物医药研发有限公司	一种Protein D与HER2融合蛋白及其制备方法和应用
NZ753307A (en)	2016-11-30	2023-10-27	Advaxis Inc	Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
CN108264550B (zh) *	2017-01-04	2021-04-23	香雪生命科学技术（广东）有限公司	一种识别源自于prame抗原短肽的tcr
CN108948184B (zh) *	2017-05-22	2021-04-23	香雪生命科学技术（广东）有限公司	一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) *	2017-08-17	2021-04-23	香雪生命科学技术（广东）有限公司	一种识别prame抗原短肽的tcr及其相关组合物
WO2019061297A1 (zh) *	2017-09-29	2019-04-04	苏州工业园区唯可达生物科技有限公司	一种cd4辅助性t细胞表位融合肽及其疫苗
EP3707152A4 (en) *	2017-11-08	2021-12-01	Advaxis, Inc.	HETEROCLITICAL IMMUNOGENIC PEPTIDES FROM CANCER-ASSOCIATED PROTEINS AND METHODS FOR USING SUCH PEPTIDES
CN109879957B (zh) *	2017-12-06	2022-03-18	香雪生命科学技术（广东）有限公司	针对prame的高亲和力t细胞受体
US20230190902A1 (en) *	2020-05-29	2023-06-22	Children's National Medical Center	Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame
AU2022270361A1 (en)	2021-05-05	2023-11-16	Immatics Biotechnologies Gmbh	Antigen binding proteins specifically binding prame

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE466259B (sv) *	1990-05-31	1992-01-20	Arne Forsgren	Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
CN1120809A (zh) *	1993-12-23	1996-04-17	Gff工业方向促进研究公司	增强免疫应答的方法
US5830753A (en)	1994-09-30	1998-11-03	Ludwig Institute For Cancer Research	Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
GB9717953D0 (en) *	1997-08-22	1997-10-29	Smithkline Beecham Biolog	Vaccine
EP1659178B1 (en) *	1998-02-05	2010-03-31	GlaxoSmithKline Biologicals SA	A process for the purification or production of a MAGE protein
CA2363118A1 (en) *	1999-02-25	2000-08-31	Smithkline Beecham Biologicals S.A.	Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
ES2250151T3 (es) *	1999-06-29	2006-04-16	Glaxosmithkline Biologicals S.A.	Uso de cpg como adyuvante de vacuna contra vih.
CN1367875A (zh) *	1999-07-08	2002-09-04	斯特思吉生物技术公司	活体外th1一样反应的诱导方法

2008
- 2008-01-11 AR ARP080100127A patent/AR064862A1/es active IP Right Grant
- 2008-01-11 CA CA002674552A patent/CA2674552A1/en not_active Abandoned
- 2008-01-11 EA EA200900795A patent/EA016326B1/ru not_active IP Right Cessation
- 2008-01-11 KR KR1020097017027A patent/KR20090101313A/ko not_active Ceased
- 2008-01-11 EP EP08701434A patent/EP2114993B1/en not_active Not-in-force
- 2008-01-11 BR BRPI0806463-6A patent/BRPI0806463A2/pt not_active IP Right Cessation
- 2008-01-11 PE PE2012001372A patent/PE20130324A1/es not_active Application Discontinuation
- 2008-01-11 HR HRP20120828AT patent/HRP20120828T1/hr unknown
- 2008-01-11 AU AU2008207025A patent/AU2008207025B2/en not_active Ceased
- 2008-01-11 US US12/013,011 patent/US20080187535A1/en not_active Abandoned
- 2008-01-11 DK DK08701434.6T patent/DK2114993T3/da active
- 2008-01-11 MY MYPI20092932A patent/MY153679A/en unknown
- 2008-01-11 PT PT08701434T patent/PT2114993E/pt unknown
- 2008-01-11 WO PCT/EP2008/050290 patent/WO2008087102A1/en not_active Ceased
- 2008-01-11 CN CN2008800078884A patent/CN101668770B/zh not_active Expired - Fee Related
- 2008-01-11 TW TW097101177A patent/TWI434697B/zh not_active IP Right Cessation
- 2008-01-11 JP JP2009545186A patent/JP5391080B2/ja not_active Expired - Fee Related
- 2008-01-11 ES ES08701434T patent/ES2393812T3/es active Active
- 2008-01-11 NZ NZ578285A patent/NZ578285A/en not_active IP Right Cessation
- 2008-01-11 PE PE2008000124A patent/PE20081686A1/es not_active Application Discontinuation
- 2008-01-11 MX MX2009007571A patent/MX2009007571A/es active IP Right Grant
- 2008-01-11 SI SI200830787T patent/SI2114993T1/sl unknown
- 2008-01-11 PL PL08701434T patent/PL2114993T3/pl unknown
- 2008-01-13 JO JO200815A patent/JO2840B1/en active
- 2008-01-14 CL CL200800104A patent/CL2008000104A1/es unknown
2009
- 2009-07-02 IL IL199663A patent/IL199663A0/en unknown
- 2009-07-02 DO DO2009000167A patent/DOP2009000167A/es unknown
- 2009-07-10 MA MA32087A patent/MA31093B1/fr unknown
- 2009-07-14 ZA ZA2009/04923A patent/ZA200904923B/en unknown
- 2009-07-15 CO CO09073705A patent/CO6210757A2/es not_active Application Discontinuation
- 2009-08-07 CR CR10971A patent/CR10971A/es unknown
2012
- 2012-11-09 CY CY20121101065T patent/CY1113760T1/el unknown

Also Published As

Publication number	Publication date
JP2010515444A (ja)	2010-05-13
CO6210757A2 (es)	2010-10-20
AR064862A1 (es)	2009-04-29
EP2114993A1 (en)	2009-11-11
CR10971A (es)	2009-09-09
AU2008207025B2 (en)	2012-08-23
ZA200904923B (en)	2012-12-27
TW200902048A (en)	2009-01-16
MA31093B1 (fr)	2010-01-04
TWI434697B (zh)	2014-04-21
MY153679A (en)	2015-03-13
NZ578285A (en)	2011-12-22
JP5391080B2 (ja)	2014-01-15
BRPI0806463A2 (pt)	2011-09-06
SI2114993T1 (sl)	2012-12-31
CY1113760T1 (el)	2016-07-27
DK2114993T3 (da)	2012-10-22
KR20090101313A (ko)	2009-09-24
PT2114993E (pt)	2012-11-28
IL199663A0 (en)	2010-04-15
EA016326B1 (ru)	2012-04-30
MX2009007571A (es)	2009-07-22
WO2008087102A1 (en)	2008-07-24
HK1138853A1 (en)	2010-09-03
EA200900795A1 (ru)	2010-02-26
EP2114993B1 (en)	2012-08-29
DOP2009000167A (es)	2009-07-15
HRP20120828T1 (hr)	2012-11-30
CA2674552A1 (en)	2008-07-24
PE20130324A1 (es)	2013-03-05
AU2008207025A1 (en)	2008-07-24
CL2008000104A1 (es)	2008-07-18
ES2393812T3 (es)	2012-12-28
CN101668770A (zh)	2010-03-10
US20080187535A1 (en)	2008-08-07
CN101668770B (zh)	2013-06-12
PE20081686A1 (es)	2008-12-25
JO2840B1 (en)	2014-09-15

Publication	Publication Date	Title
DK2114993T3 (da)	2012-10-22	Vaccine
ATE450271T1 (de)	2009-12-15	Impfstoff
DK2200646T3 (da)	2013-10-21	RNA-Vacciner
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
DE502007001207D1 (de)	2009-09-10	Elektrosaugkopf
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
DE112008003636A5 (de)	2010-10-21	Mehrzuggruppierer
DE602008000923D1 (de)	2010-05-20	Einzelwaferätzgerät
DE602008000749D1 (de)	2010-04-15	Buschschneider
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
DK2125048T3 (da)	2014-10-13	Præparat
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
AT505058A3 (de)	2008-12-15	Türschliesssystem
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
DE502008001694D1 (de)	2010-12-16	Mitfahrhubwagen
DE112008003196A5 (de)	2011-02-03	Handpipettiergerät
BRPI0921578A2 (pt)	2019-09-24	vacinas unitemporais
DE602008000292D1 (de)	2009-12-31	Werkzeughaltepositioniervorrichtung
DE502008003063D1 (de)	2011-05-19	Magnetventilinjektor
DE112008002200A5 (de)	2010-09-23	Sperrsynchronisiervorrichtung
CU20090155A7 (es)	2011-04-26	Macrolidos